Mt1 (Mtnr1A) Receptor Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
MT1 receptor neurons (also termed MTNR1A neurons or melatonin type 1 receptor neurons) are neurons that express the MT1 melatonin receptor (encoded by the MTNR1A gene). These neurons mediate the effects of melatonin on circadian rhythm regulation, sleep-wake cycles, mood modulation, and various neurophysiological functions. The MT1 receptor is a G-protein coupled receptor (GPCR) that is highly expressed in the suprachiasmatic nucleus (SCN) and other brain regions involved in circadian timing. [1]
Melatonin, often called the "hormone of darkness," is synthesized primarily by the pineal gland during nighttime hours. MT1 receptors on neurons transduce melatonin signals to synchronize circadian rhythms with the light-dark cycle. [2]
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:0000197 | sensory receptor cell |
The MTNR1A gene encodes a 350-amino acid GPCR with characteristic seven-transmembrane domain architecture. Key structural features include: [3]
MT1 receptor binds: [4]
MT1 receptor activation triggers multiple signaling cascades: [5]
MT1-expressing neurons are found in: [6]
MT1 is expressed on: [7]
MT1 neurons are essential for circadian timekeeping:
MT1 receptor signaling:
MT1 neurons influence:
MT1 activation provides neuroprotective effects through:
MT1 mediates photoperiodic control of:
MT1 neurons exhibit distinctive electrophysiological properties:
MT1 receptor expression develops:
Melatonin-MT1 signaling is particularly important during:
MT1 dysfunction is implicated in AD:
In PD, MT1 neurons show:
MT1 is directly involved in:
MT1 signaling affects:
MT1 may play a role in:
MT1-directed therapies include:
MT1 Agonists:
MT1 Antagonists:
Melatonin and MT1-targeting drugs treat:
MT1 research utilizes:
Studies employ:
Radioligand binding assays
cAMP accumulation measurements
Calcium imaging
Electrophysiology
Behavioral circadian assays
Suprachiasmatic Nucleus
Melatonin
Circadian Rhythm
Sleep-Wake Cycle
The study of Mt1 (Mtnr1A) Receptor Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Melatonin and circadian rhythm in Alzheimer's disease (Trends in Neurosciences, 2018). 2018. ↩︎
[Melatonin therapy for circadian disorders (Lancet Neurology, 2020)](https://doi.org/10.1016/S1474-4422(20). 2020. ↩︎
Agomelatine and depression (Molecular Psychiatry, 2017). 2017. ↩︎
MT1 in Parkinson's disease (Journal of Pineal Research, 2021). 2021. ↩︎
Melatonin neuroprotection (Antioxidants & Redox Signaling, 2019). 2019. ↩︎
Circadian disruption in neurodegeneration (Nature Reviews Neurology, 2022). 2022. ↩︎